Removal of Acrolein from Active Pharmaceutical Ingredients Using Aldehyde Scavengers
- 14 May 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 16 (6), 1225-1229
- https://doi.org/10.1021/op3000459
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Approaches to Assessment, Testing Decisions, and Analytical Determination of Genotoxic Impurities in Drug SubstancesOrganic Process Research & Development, 2008
- Recent Advances in the Impurity Profiling of DrugsCurrent Pharmaceutical Analysis, 2008
- Regulating impurities in pharmaceutical products: a tolerability of risk approach?Expert Review of Clinical Pharmacology, 2008
- Toxicological overview of impurities in pharmaceutical productsAdvanced Drug Delivery Reviews, 2007
- Determination of genotoxic phenylhydrazine agaritine in mushrooms using liquid chromatography–electrospray ionization tandem mass spectrometryFood Additives & Contaminants, 2006
- Regulation of genotoxic and carcinogenic impurities in drug substances and productsTrAC Trends in Analytical Chemistry, 2006
- The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug developmentRegulatory Toxicology and Pharmacology, 2006
- A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicityRegulatory Toxicology and Pharmacology, 2006
- Carcinogenicity categorization of chemicals—new aspects to be considered in a European perspectiveToxicology Letters, 2004
- Acceptability of Low Levels of Genotoxic Impurities in New Drug SubstancesInternational Journal of Pharmaceutical Medicine, 2004